mitoNice
Nice Acropolis Congress Center Nice, FranceIn September, Abliva will attend mitoNice, an international congress dedicated to Mitochondrial Medicine.
Loading view.
Hadean Investor Day
Oslo , NorwayMore info to come.
Aktiedagen Lund
Elite Hotel Ideon Scheelevägen 27, Lund, SwedenOn September 26 (Monday), 2022, Abliva will attend Aktiespararna's Aktiedagen Lund, at Elite Hotel Ideon. CEO Ellen Donnelly will present the company at 4 p.m. CEST. See below for more info and registration.
Nordic Life Science Days 2022
Malmömässan Mässgatan 6, Malmö, SwedenAbliva will attend the Nordic Life Science Days in Malmö, Sweden, on September 28-29, 2022. CEO Ellen Donnelly will be presenting the company at 11:00 CEST on Sep 29.
Mitocon’s Mitochondrial Diseases Conference
Holiday Inn Rome EUR Parco dei Medici Rome, ItalyIn October, Abliva will attend the Italian patient organization Mitocon's annual Mitochondrial Diseases Conference in Rome, Italy. On October 8, Abliva's Chief Medical Officer Magnus Hansson will give the talk: An adaptive, clinical Phase 2/3 study evaluating the efficacy of KL1333 in adult primary mitochondrial disease patients in Session 5: Challenges and pitfalls in clinical […]
Shareholders’ meeting in Olofström
Olofström , SwedenAbliva will visit Aktiespararna Västra Blekinge/Bromölla in Olofström on November 8, 2022. Abliva's CFO Catharina Johansson and Communications Officer Eleonor Åsander Frostner will be presenting the company during the evening. See below for more info and registration.
Shareholders’ meeting in Tommarp
Tommarps bygdegård Storgatan 52, Tommarp, SwedenAbliva will come to Aktiespararna's local club Sydöstra Skåne, in Tommarp, Sweden, on November 17, 2022. Abliva’s CFO Catharina Johansson and Communications Officer Eleonor Åsander Frostner will be presenting the company during the evening. See below for more info and registration.
Mitochondrial Medicine – Therapeutic Development
Wellcome Genome Campus Hinxton, United KingdomIn late November, Abliva will attend the annual scientific conference Mitochondrial Medicine - Therapeutic Development in Hinxton, UK. Abliva's Chief Medical Officer, Magnus Hansson, will present a poster on one of the important preparatory studies for the upcoming, potentially registrational, Phase 2 study, FALCON, with KL1333 in patients with mitochondrial diseases.
Stora Aktiedagen Stockholm
Hotel Birger Jarl Tulegatan 8, Stockholm, SwedenIn late November, Abliva will attend Aktiespararna's Stora Aktiedagen Stockholm. The company's CEO, Ellen Donnelly, will present the company via Zoom on November 29, 2022, at 7:30 p.m. CET. See below for detailed information and a link to the event.
Nordic American Life Science Conference 2022
Shearman & Sterling 599 Lexington Ave, New York, NY, United StatesIn December 2022, Abliva will attend the 7th Annual Nordic American Life Science Conference, hosted by DNB, Nasdaq, and Business Sweden, in New York, US. Abliva's CEO Ellen Donnelly will present the company on December 8.
BioStock Investor Meeting
Abliva will attend the virtual BioStock Investor Meeting on March 16, 2023. CEO Ellen Donnelly will be presenting the company in BioStock's studio in Lund. The event will be broadcasted online on the BioStock website and YouTube channel.
BIO-Europe Spring Digital
VirtualWe will digitally attend this year's BIO-Europe spring, hosted in Basel, Switzerland, on March 20 - 22, 2023. This major life science and biotech meeting offers a great opportunity for networking and partnering.